Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Monopar Therapeutics Inc.
Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in Advanced Cancers
August 21, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr
August 14, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments
August 09, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Therapeutics Announces 1-for-5 Reverse Stock Split
August 09, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmaceutical MNPR-101-Zr
July 09, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24
June 25, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar and NorthStar Amend & Extend Collaboration
June 11, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead Clinical Program at the 2024 SNMMI Annual Meeting
June 10, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Announces CFO Succession
May 24, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline
May 09, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
April 18, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
April 16, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients
April 10, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments
March 28, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program
March 05, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial
February 27, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers
February 22, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers
February 20, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments
November 09, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Presents Data Showing Tumor Reduction Benefit of Camsirubicin from Ongoing Phase 1b at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting
November 01, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar to Participate in the Roth MKM 2023 Healthcare Opportunities Conference
October 10, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Therapeutics Reports Second Quarter 2023 Financial Results and Recent Developments
August 10, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Provides Encouraging Camsirubicin Clinical Data Update
August 08, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Announces MNPR-101 Radiopharma Collaboration Agreement with National University of Singapore
July 11, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar to Participate in the Radiopharma Forum by the Lake 2023
June 21, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar to Participate in the Maxim Group’s Healthcare Virtual Conference
June 14, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Announces Encouraging Camsirubicin Phase 1b Trial Update
June 01, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar Therapeutics Reports First Quarter 2023 Financial Results and Recent Developments
May 11, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Monopar to Present at the Jefferies Radiopharma Innovation Summit
March 28, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Tickers
MNPR
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.